CG
ONC

Cutler Group’s BeOne Medicines Ltd ONC Stock Holding History

Cutler Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-714
Closed -$171K – 4881
2022
Q4 		$157K Buy
+714
New +$131K 0.01% 914
2022
Q3 		– Sell
-40
Closed -$6K – 5649
2022
Q2 		$6K Sell
40
-10
-20% -$1.56K ﹤0.01% 3631
2022
Q1 		$9K Buy
+50
New +$10.6K ﹤0.01% 3730
2021
Q1 		– Sell
-1,550
Closed -$513K – 6436
2020
Q4 		$400K Buy
1,550
+1,250
+417% +$344K 0.02% 732
2020
Q3 		$85K Buy
+300
New +$70.5K 0.01% 1429
2020
Q2 		– Sell
-3,423
Closed -$557K – 5014
2020
Q1 		$421K Buy
3,423
+925
+37% +$145K 0.02% 616
2019
Q4 		$414K Buy
2,498
+1,702
+214% +$283K 0.03% 519
2019
Q3 		$97K Buy
+796
New +$106K 0.01% 1085
2019
Q2 		– Sell
-2,400
Closed -$305K – 4910
2019
Q1 		$316K Buy
2,400
+600
+33% +$81K 0.03% 467
2018
Q4 		$252K Buy
+1,800
New +$239K 0.02% 540
2018
Q3 		– Sell
-1,417
Closed -$238K – 4818
2018
Q2 		$217K Buy
+1,417
New +$253K 0.02% 743

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Cutler Group's ONC Position: Q1 2023 in Review

Cutler Group sold out of BeOne Medicines Ltd (ONC) in Q1 2023, closing a stake of 714 shares — an estimated $171K sold.

Cutler Group first reported a position in ONC in Q2 2018 and held it in 11 quarters. The position peaked at $421K in Q1 2020. 220 funds tracked by Wall St. Rank hold ONC as of Q1 2023.

  • Cutler Group reported no remaining BeOne Medicines Ltd position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 714 BeOne Medicines Ltd shares in Q1 2023, an estimated $171K.
  • Cutler Group first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 11 quarters.
  • Cutler Group's BeOne Medicines Ltd position peaked at $421K in Q1 2020.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.